-+ 0.00%
-+ 0.00%
-+ 0.00%

PROPANC BIOPHARMA ADVANCES BIOANALYTICAL & IMMUNOGENICITY ASSAY DEVELOPMENT FOR PHASE 1B FIRST-IN-HUMAN STUDY IN UP TO 50 ADVANCED CANCER PATIENTS

Reuters·10/30/2026 12:30:01

Please log in to view news